Vaccine

Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations

Target enrollment of 6,000 participants completed in the Northern Hemisphere Planned interim analysis in Q1 2026 will determine potential need…

4 weeks ago

Beat the End-of-Year Healthcare Rush with FSA- and HSA-eligible Telehealth at FSA Store® and HSA Store®

Take advantage of special savings on telehealth services from BetterHelp, Bilt Labs, Daybreak, and MEDVi–and digital health from OURA–when you…

4 weeks ago

Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management

Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibilityCompany reiterates 2025 financial guidance provided on 3Q25…

4 weeks ago

Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management

Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibilityCompany reiterates 2025 financial guidance provided on 3Q25…

4 weeks ago

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine…

4 weeks ago

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026Expects to expand seasonal vaccine…

4 weeks ago

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

AUSTIN, Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: As late-stage biotech pipelines mature, fair-value remeasurements under U.S.…

4 weeks ago

Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1

Evaxion’s AI-Immunology™ platform has discovered novel CMV antigens that significantly reduce viral infection in preclinical models EVX-V1 is a next-generation, multi-component…

4 weeks ago

Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines VAXXITEK® HVT+IBD+H5 and VAXXINACT® H5

Chickens in a barn Boehringer Ingelheim image The European Medicines Agency’s (EMA’s) Committee for Veterinary Medicinal Products (CVMP) has adopted…

4 weeks ago

Cognizant selected by CEPI to transform enterprise architecture and core ERP operations

OSLO, Norway, Nov. 20, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH), a leading global professional services company, today announced that it has…

4 weeks ago